James A. Jr. Robinson Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James A. Jr. Robinson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James A. Jr. Robinson. James A. Jr. Robinson is a Director in Neos Therapeutics, Inc. ($NEOS) and a President & COO,Alkermes, Inc. in Alkermes plc. ($ALKS) and a Director in Urovant Sciences Ltd. ($UROV) and a PEO; CEO/Urovant Sciences, Inc in Urovant Sciences Ltd. ($UROV) and a PEO;CEO/Urovant Sciences, Inc. in Urovant Sciences Ltd. ($UROV).
Address: 852 WINTER ST. WALTHAM 02451 MA
Companies in which James A. Jr. Robinson is an Insider
Alkermes plc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James A. Jr. Robinson: President & COO,Alkermes, Inc.
Holdings: 6,250 shares
Current Value: $342,313
Latest Transaction: Apr 05 2019
$ALKS Market Capitalization: $8.28B
$ALKS Previous Close: $54.77
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Neos Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James A. Jr. Robinson: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 19 2021
$NEOS Market Capitalization: $81.10M
$NEOS Previous Close: $5.00
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Urovant Sciences Ltd.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of James A. Jr. Robinson: PEO; CEO/Urovant Sciences, Inc, PEO;CEO/Urovant Sciences, Inc., Director
Holdings: 8,385 shares
Latest Transaction: Jan 12 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of James A. Jr. Robinson
Sentiment: All, ALKS, NEOS, UROV
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Robinson James A. Jr. | Director | Option Exercise | D | 1.44 | 46,907 | 67,546 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Robinson James A. Jr. | Director | Option Exercise | D | 2.03 | 12,500 | 25,375 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Robinson James A. Jr. | Director | Sell | D | 0.00 | 23,453 | 0 | 0 | 23.5 K to 0 (-100.00 %) |
| Jan 12 2021 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | PEO; CEO/Urovant Sc ... | Payment of Exercise | F | 16.11 | 4,095 | 65,970 | 8,385 | 12.5 K to 8.4 K (-32.81 %) |
| Jun 11 2020 | NEOS | Neos Therapeutics, ... | Robinson James A. Jr. | Director | Grant | A | 0.00 | 23,453 | 0 | 23,453 | 0 to 23.5 K |
| Mar 25 2020 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | PEO;CEO/Urovant Sci ... | Option Exercise | A | 9.16 | 845,732 | 7,746,905 | 845,732 | |
| Jan 14 2020 | UROV | Urovant Sciences L ... | Robinson James A. Jr. | Director | Grant | A | 0.00 | 12,480 | 0 | 12,480 | 0 to 12.5 K |